N. Peiffer-smadja, J. Lucet, and G. Bendjelloul, Challenges and issues about organising a hospital to respond to the COVID-19 outbreak: experience from a French reference centre, Clin Microbiol Infect, 2020.

W. W. Fleischhacker, M. Cetkovich-bakmas, D. Hert, and M. , Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challenges, J Clin Psychiatry, vol.69, pp.514-523, 2008.

L. E. Ross, S. Vigod, and J. Wishart, Barriers and facilitators to primary care for people with mental health and/or substance use issues: a qualitative study, BMC Fam Pract, vol.16, p.135, 2015.

S. Ministère-des, L. De, and . Santé, Consignes et recommandations applicables à l'organisation des prises en charge dans les services de psychiatrie et les établissements sanitaires autorisés en psychiatrie, 2020.

M. Percudani, M. Corradin, and M. Moreno, Mental health services in Lombardy during COVID-19 outbreak, Psychiatry Res, vol.288, p.112980, 2020.

J. Rehm and K. D. Shield, Global burden of disease and the impact of mental and addictive disorders, Curr Psychiatry Rep, vol.21, issue.10, 2019.

E. R. Walker, R. E. Mcgee, and B. G. Druss, Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis, JAMA Psychiatry, vol.72, pp.334-375, 2015.

A. Chevance, D. Gourion, and N. Hoertel, Ensuring mental health care during the SARS-CoV-2 epidemic in France: a narrative review, Encéphale 2020

, Groupe ressource PSY/COVID-19 Conférence nationale des présidents de CME/CHS. Les secteurs de psychiatrie à l'heure de la sortie du confinement, 2020.

M. Plaze, D. Attali, and A. Petit, Repositionnement de la chlorpromazine dans le traitement du COVID-19 : étude reCoVery, vol.2020

K. Farsalinos, R. Niaura, L. Houezec, and J. , Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system, Toxicol, vol.2020